MODULE 1 ยท GDFM PROGRAMME

Nose and Throat Conditions

๐Ÿ“… ๐Ÿ› College of Family Physicians Singapore

Learning Objectives

  • ๐Ÿ’Ž Differentiate allergic vs vasomotor rhinitis and apply current treatment guidelines (ARIA 2024โ€“25)
  • ๐Ÿ’Ž Recognise and manage acute bacterial rhinosinusitis โ€” know when to use antibiotics
  • ๐Ÿ’Ž Approach epistaxis: distinguish anterior vs posterior bleeds and manage accordingly
  • ๐Ÿ’Ž Identify red flags in hoarseness requiring urgent ENT referral
  • ๐Ÿ’Ž Screen and manage obstructive sleep apnea in primary care, including newer therapies
  • ๐Ÿ’Ž Evaluate a neck mass โ€” differentiate infection, inflammation, and malignancy

Rhinitis: Allergic vs Vasomotor

  • ๐Ÿ’Ž Allergic Rhinitis (AR): pale, grey, boggy mucosa โ€” IgE-mediated, triggered by allergens (house dust mite, pollen)
  • ๐Ÿ’Ž Vasomotor Rhinitis (VMR): beefy red turbinates โ€” non-allergic triggers (temperature, smoke, irritants)
  • ๐Ÿšจ Rhinitis Medicamentosa: rebound swelling after >2 weeks of topical decongestant use โ€” STOP the spray
  • ๐Ÿ’Ž AR Classification: Intermittent (<4 days/wk, <4 wks) vs Persistent (>4 days/wk, >4 wks)
  • ๐Ÿšจ Red flags in children: unilateral symptoms, bloody discharge, CN signs โ†’ refer ENT

Allergic Rhinitis: Updated Treatment (ARIA 2024โ€“25)

  • ๐Ÿ’Ž First-line: Intranasal corticosteroid (INCS) โ€” most effective single agent for AR
  • ๐Ÿ’Ž Combination INCS + intranasal antihistamine (MP-AzeFlu / Dymistaยฎ) โ€” superior to monotherapy for moderate-to-severe AR
  • ๐Ÿ’Ž Oral antihistamines for breakthrough symptoms, especially ocular/cutaneous features
  • ๐Ÿšจ Avoid LTRAs (montelukast) as first-line in patients โ‰ฅ15 yrs โ€” less favourable benefitโ€“risk profile
  • ๐Ÿ’Ž Severe CRS with nasal polyps (CRSwNP): dupilumab (biologic) โ€” refer for specialist assessment
  • ๐Ÿ’Ž Immunotherapy (SCIT/SLIT) for moderate-to-severe AR poorly controlled by pharmacotherapy

Rhinosinusitis: Diagnosis & Antibiotic Stewardship

  • ๐Ÿ’Ž Diagnosis: โ‰ฅ2 symptoms, one must be nasal blockage OR purulent discharge
  • ๐Ÿ’Ž Viral ARS (<10 days): symptomatic treatment only โ€” no antibiotics
  • ๐Ÿšจ ABRS suspected if: symptoms >10 days without improvement OR 'double worsening'
  • ๐Ÿšจ EPOS 2020: Consider ABRS if โ‰ฅ3 of 5 โ€” unilateral discharge, severe pain, fever โ‰ฅ38ยฐC, double sickening, raised CRP/ESR
  • ๐Ÿ’Ž Even in ABRS: watchful waiting preferred for systemically well patients โ€” antibiotics if unwell or risk factors
  • ๐Ÿšจ Refer to ED: periorbital cellulitis, diplopia, meningismus โ€” complications of sinusitis

Epistaxis

  • ๐Ÿ’Ž Most bleeds: anterior, from Kiesselbach's plexus (Little's area) โ€” venous in young, arterial in elderly
  • ๐Ÿ’Ž First aid: pinch soft alar cartilage firmly, lean forward โ€” hold for 10โ€“15 minutes
  • ๐Ÿšจ Posterior epistaxis: blood drains down pharynx, source not visible anteriorly โ€” urgent ENT referral
  • ๐Ÿšจ NPC red flags: epistaxis + unilateral hearing loss + neck mass + CN palsies โ†’ urgent workup
  • ๐Ÿ’Ž Assess haemodynamic stability first โ€” posterior bleeds can be profuse

Hoarseness & Dysphonia

  • ๐Ÿšจ REFER if hoarseness >2 weeks without apparent benign cause โ€” rule out laryngeal carcinoma
  • ๐Ÿ’Ž Key red flags: dysphagia, hemoptysis, otalgia โ€” especially in smokers/heavy drinkers
  • ๐Ÿ’Ž Vocal quality clues: breathiness โ†’ VC paralysis; worse in morning โ†’ LPR; worse later โ†’ myasthenia gravis
  • ๐Ÿšจ Do NOT prescribe antibiotics or corticosteroids for dysphonia without laryngoscopy
  • ๐Ÿ’Ž Vocal hygiene: hydration, avoid irritants, voice rest โ€” effective for benign lesions
  • ๐Ÿ’Ž VC paralysis: unilateral = breathy weak voice; bilateral = adducted cords + compromised airway

Foreign Body: Swallowed Fish Bone

  • ๐Ÿ’Ž Most common site: tonsil (31.8%) โ†’ pain at jaw/upper neck
  • ๐Ÿ’Ž Inspect systematically: tonsillar poles โ†’ tonsillo-lingual sulcus โ†’ valleculae
  • ๐Ÿšจ Button batteries = emergency โ€” chemical necrosis within hours โ€” immediate removal
  • ๐Ÿ’Ž Laryngeal rocking test: pain on rocking thyroid cartilage โ†’ upper cervical esophagus impaction
  • ๐Ÿšจ Non-contrast CT neck if no FB seen on exam or lateral X-ray โ€” CT has replaced barium swallow
  • ๐Ÿšจ Refer if: removal unsuccessful, rocking test positive, esophageal FB on imaging, chest pain/dysphagia

Obstructive Sleep Apnea (OSA)

  • ๐Ÿ’Ž Screen: loud snoring + witnessed apneas + EDS (ESS โ‰ฅ10) โ€” also fatigue/lack of energy
  • ๐Ÿ’Ž Severity: mild AHI 5โ€“14, moderate 15โ€“29, severe โ‰ฅ30 events/hour
  • ๐Ÿ’Ž CPAP: first-line for moderate-to-severe OSA โ€” pneumatic splint, reduces CV risk
  • ๐Ÿ’Ž Oral appliances (MAD): alternative for mild-to-moderate OSA or CPAP-intolerant patients
  • ๐Ÿšจ Hypoglossal Nerve Stimulation (Inspireยฎ): AHI 15โ€“65, BMI <35, no complete concentric velum collapse on DISE
  • ๐Ÿ’Ž Lifestyle: weight loss, positional therapy, avoid alcohol/sedatives before sleep

Neck Masses: Evaluation in Adults

  • ๐Ÿšจ Assume malignant until proven otherwise: duration โ‰ฅ2 weeks, firm/hard, fixed, non-tender, >1.5 cm
  • ๐Ÿ’Ž Infection: tender, erythematous, warm, associated with URTI/dental โ€” treat with amoxicillin-clavulanate
  • ๐Ÿšจ Partial/no response to antibiotics โ†’ must exclude malignancy โ€” refer for FNA
  • ๐Ÿ’Ž Midline mass that moves on swallowing or tongue protrusion โ†’ Thyroglossal Duct Cyst (TGDC)
  • ๐Ÿ’Ž Lateral soft cystic mass ยฑ discharge history โ†’ Branchial Cleft Cyst โ€” FNA to exclude malignancy
  • ๐Ÿ’Ž Ultrasound increasingly used as first-line imaging at point of referral before FNA

Key Takeaways

Key Point
๐Ÿ’Ž AR vs VMR: boggy pale mucosa vs beefy red โ€” treat AR with INCS first; add MP-AzeFlu (Dymista) if insufficient
Key Point
๐Ÿ’Ž Sinusitis: antibiotics only for ABRS with systemic features โ€” watchful waiting for most
Key Point
๐Ÿšจ Epistaxis: pinch alae + lean forward; posterior bleed โ†’ urgent ENT
Key Point
๐Ÿšจ Hoarseness >2 weeks = ENT referral to rule out malignancy
Key Point
๐Ÿ’Ž OSA: CPAP first-line; HNS (Inspire) for CPAP-intolerant (AHI 15โ€“65, BMI <35)
Key Point
๐Ÿšจ Neck mass: firm, non-tender, >2 weeks = malignant until proven otherwise โ†’ FNA

Key References

  • ARIA-EAACI Guidelines 2024โ€“2025 Revision: Intranasal Treatments. Allergy. 2025. DOI:10.1111/all.70131
  • Rosenfeld RM et al. Clinical Practice Guideline (Update): Adult Sinusitis. Otolaryngol Head Neck Surg. 2015
  • Stachler RJ et al. Clinical Practice Guideline: Hoarseness (Dysphonia) Update. Otolaryngol HNS. 2018
  • Kapur VK et al. AASM Clinical Practice Guideline for Diagnostic Testing for Adult OSA. J Clin Sleep Med. 2017
  • AASM Manual for Scoring of Sleep and Associated Events, Version 3. AASM, 2023
  • Pynnonen MA et al. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults. Otolaryngol HNS. 2017